Morningstar Investment Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,012
Closed -$202K 227
2022
Q1
$202K Sell
5,012
-19
-0.4% -$677 ﹤0.01% 231
2021
Q4
$202K Buy
+5,031
New +$188K ﹤0.01% 234
2021
Q3
Sell
-5,000
Closed -$229K 226
2021
Q2
$229K Hold
5,000
﹤0.01% 207
2021
Q1
$205K Hold
5,000
﹤0.01% 201
2020
Q4
$214K Buy
+5,000
New +$180K ﹤0.01% 198
2020
Q1
Sell
-10,000
Closed -$177K 217
2019
Q4
$177K Hold
10,000
﹤0.01% 196
2019
Q3
$155K Hold
10,000
﹤0.01% 189
2019
Q2
$172K Hold
10,000
﹤0.01% 211
2019
Q1
$161K Hold
10,000
﹤0.01% 202
2018
Q4
$146K Hold
10,000
﹤0.01% 204
2018
Q3
$182K Hold
10,000
﹤0.01% 199
2018
Q2
$169K Hold
10,000
﹤0.01% 200
2018
Q1
$196K Hold
10,000
﹤0.01% 197
2017
Q4
$203K Hold
10,000
﹤0.01% 196
2017
Q3
$174K Hold
10,000
﹤0.01% 194
2017
Q2
$128K Hold
10,000
﹤0.01% 185
2017
Q1
$130K Hold
10,000
﹤0.01% 181
2016
Q4
$99K Hold
10,000
﹤0.01% 188
2016
Q3
$121K Hold
10,000
﹤0.01% 218
2016
Q2
$91K Hold
10,000
﹤0.01% 211
2016
Q1
$95K Hold
10,000
﹤0.01% 215
2015
Q4
$173K Hold
10,000
0.01% 204
2015
Q3
$134K Hold
10,000
0.01% 208
2015
Q2
$226K Sell
10,000
-2,500
-20% -$43.9K 0.01% 201
2015
Q1
$179K Sell
12,500
-10,000
-44% -$144K 0.01% 205
2014
Q4
$217K Buy
+22,500
New +$200K 0.01% 207

Other funds holding HALO

Morningstar Investment Services's HALO Position: Q2 2022 in Review

Morningstar Investment Services sold out of Halozyme (HALO) in Q2 2022, closing a stake of 5,012 shares — an estimated $202K sold.

Morningstar Investment Services first reported a position in HALO in Q4 2014 and held it in 26 quarters. The position peaked at $229K in Q2 2021. 367 funds tracked by Wall St. Rank hold HALO as of Q2 2022.

  • Morningstar Investment Services reported no remaining Halozyme position as of Q2 2022 after selling out during the quarter.
  • Morningstar Investment Services sold 5,012 Halozyme shares in Q2 2022, an estimated $202K.
  • Morningstar Investment Services first reported a position in Halozyme in Q4 2014 and held it in 26 quarters.
  • Morningstar Investment Services's Halozyme position peaked at $229K in Q2 2021.
  • 367 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.

Based on Morningstar Investment Services's 13F filing for Q2 2022, filed 12 Aug 2022.